Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that a summary of the final clinical trial results for the randomized study of Cook Medical's Zilver® PTX® Drug-Eluting Peripheral Stent for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery...
Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...
More...
Akorn, Inc. (NASDAQ:AKRX) a niche generic pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA)...
Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, today has introduced its latest Continua™ Certified device, the 1000USB-C USB adapter. Designed for OEM system developers, the 1000USB-C adapter enables any of Nonin's handheld oximeters to conveniently...
Language Line Services, the leading provider of language-based solutions and the number one provider of over-the-phone interpreting services for the healthcare industry, announced a program of support, instructional materials and consultations to help ensure compliance for hospitals as they gear...
Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome...
BioAlliance Pharma SA (Paris:BIO)(Euronext Paris - BIO), a company dedicated to the supportive care and treatment of cancer patients, announced the grant of a European patent protecting its product acyclovir Lauriad®. This patent is now validated in all European countries; this first patent...
Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90 per cent of metastatic breast carcinoma (MBC) patients. Correlations were observed with both the patients' monocyte (i.e...
Agriculture Secretary Tom Vilsack today announced the funding of a project in New York that will improve wastewater services for the Village of Monticello, create construction jobs and support community development. The project is funded through the American Recovery and Reinvestment Act...
Agriculture Secretary Tom Vilsack announced the funding of a project in California that will improve wastewater services for the community of Los Osos, create construction jobs and support community development. USDA officials made the announcement at the San Luis Obispo County Government Center...
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of...
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with LytixarTM (LTX-109) treatment of skin infections caused by Gram positive bacteria. According to Lytix Biopharma CEO Gunnar Sælid, "We are delighted to...
Eisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Application (NDA) for locally advanced or metastatic breast cancer on or before December 30, 2010...
HHS Secretary Kathleen Sebelius announced the expansion of the Centers for Medicare & Medicaid Services' (CMS) Rural Community Hospital demonstration program, through the Affordable Care Act. Up to 20 small rural hospitals in selected states will be eligible for enhanced reimbursement for...
CareFusion (NYSE: CFN), a leading, global medical device company, announced the national commercial launch of the AVAmax® Vertebral Balloon, a minimally invasive device for use during kyphoplasty, a procedure for treating spinal compression fractures. The AVAmax Vertebral Balloon represents...
The U.S. Department of Health and Human Services expanded Medicare coverage of evidence-based tobacco cessation counseling, removing a barrier to treatment for all tobacco users covered by Medicare. Before today's decision, Medicare had covered tobacco counseling only for individuals diagnosed...
The new handset supports YouTube and other Flash content via Adobe Flash Lite, comes with a 5-megapixel camera with 8x zoom, flash and advanced shooting and editing capabilities.
The Biotechnology Industry Organization (BIO) announced the initial selection of 2010 presenting companies for the 9th Annual BIO Investor Forum, taking place at the Palace Hotel in San Francisco, Calif. on October 5-6. "The 2010 BIO Investor Forum is attracting significant interest from...